Slideshow
Author(s):
New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.
Ahead of the Pain: AHN's Approach to Treating Migraine
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
Tavapadon Meets Primary and Secondary End Points in Phase 3 TEMPO-2 Trial for Early Parkinson Disease
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
APOE4 Allele Carriers and Parkinson Disease Named Among Highest Risk Factors for Epilepsy in Patients With Dementia
System Integration: How AI Is Weaving Itself into Neurology